Pro-Dex, Inc. (PDEX) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $52.77. It has a SharesGrow Score of 71/100, indicating a above average investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of PDEX = $33.22 (-37% from the current price, the stock appears overvalued).
Valuation: PDEX trades at a trailing Price-to-Earnings (P/E) of 14.2 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 12.16.
Financials: revenue is $67M, +16.7%/yr average growth. Net income is $9M, growing at +102.3%/yr. Net profit margin is 13.5% (healthy). Gross margin is 29.3% (-1.9 pp trend).
Balance sheet: total debt is $17M against $37M equity (Debt-to-Equity (D/E) ratio 0.45, conservative). Current ratio is 3.23 (strong liquidity). Debt-to-assets is 27.1%. Total assets: $61M.
Analyst outlook: 1 / 1 analysts rate PDEX as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 30/100 (Fail), Growth 90/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 25/100 (Fail), Future 100/100 (Pass), Income 55/100 (Partial).
